Treatment with propranolol during MDA-MB-231 tumour development blocked chronic stress from increasing tumour LYVE-1+ LVD and reduced metastasis to lymph nodes, suggesting that reduced LVD had functional effects on tumour cell dissemination (Fig. 3a and Supplementary Table 1). The gene discussed is LYVE1; the disease is neoplasm.